R. Caporali, R. Ravasio, P. Raimondo, and F. Salaffi, “Erratum in: Cost per responder for upadacitinib vs abatacept in patients with moderate-to-severe Rheumatoid Arthritis in Italy”, Grhta, vol. 9, no. 1, p. 30, Feb. 2022.